The World Health Organization (WHO) operates a prequalification programme to assess the quality, safety and efficacy of products that address global public health priorities. Pre-qualified products are listed on the WHO website as eligible for procurement, giving purchasing agencies such as UNICEF a range of quality-assured diagnostics, medicines and vaccines from which to choose. Charles River Associates was asked to support the development of a new financing arrangement that addressed the needs of all stakeholders, including industry groups, key partners and the WHO.
To read more, click the link below.
From ASP to MFP: The looming disruption of the medical benefit
Key recent developments in the program include: The first two years of the MDPNP only covered retail-dispensed therapies but starting in this selection...